Gastrointestinal Malignancy Cures: A Molecular Biology Approaches

Joseph Abraham^*
*Correspondence: Joseph Abraham, Department of Microbiology, University of Copenhagen, Denmark, Email:

Keywords

Molecular biology • Gastrointestinal Malignancy

Introduction

Introduction

Humans are filled up with people or other living things by many, many bacteria including bacteria, archaea, organism with cells that have nuclei within membranes, and viruses, although bacteria are the most plentiful and well-studied part. The (combination of different substances, objects, people, etc. stomach- and intestine-related (GI) microbiome is shaped by a variety of factors including diet, added related to surrounding conditions or the health of the Earth elements, and the related to tiny chemical assembly instructions inside of living things background of the host. The GI microbiota is a complex community that contains millions of tiny chemical assembly instructions inside of living things, translating into secret code enzymes that create metabolites that can influence health as well as disease.

Generally speaking, stomach- and intestine-related cancers are more likely to develop in men, and the risk increases with age. Studies have linked these cancers to cigarette smoking, alcohol drinking and unhealthy diets.

Tumors may also result from specific hidden under conditions--like gastroesophageal stomach-acid pain disease in the esophagus, Helicobacter pylori infection in the stomach, disease where blood sugar swings wildly in the pancreas, insulting bowel disease in the large intestine colon and rectum, liver disease B or C virus infection or liver disease in the liver.

Most of the time, signs of stomach- and intestine-related cancers don't happen until the tumor has become more advanced. Then, they depend on the type of cancer. Patients with esophageal cancer may have difficulty swallowing, whereas those with stomach-related cancer will see open, painful sore-like signs of sickness e.g., indigestion, loss of desire to eat something, swelling and pain. Liver cancer and related to the pancreas cancer can also lead to related to the center part of the body pain, and related to the intestines and rectum cancer--as you might expect--causes changes in bowel function or bleeding [1-2].

If patients have signs of sickness and the doctor has reason to suspect an identification of a disease or problem, or its cause of stomach- and intestinerelated cancer, they may do some of the following tests: Endoscopy or esophagogastroduodenoscopy (EGD) to check the lining of the esophagus, stomach and small intestine for tumors, medical examination of intestines to check the colon and rectum for abnormal growths, which can become containing cancer, Lab tests to look for changes in the blood that could be signs of cancer, Imaging studies MRI, X-ray, ultrasound, CT scan or PET scan to check for different from what's usually expected tissue anywhere in the digestive system, take a sample of living tissue for analysis to get a sample of different from what's usually expected tissue and carefully study it for the presence of cancer cells. When the tumor is easy to reach, surgery might be all that's necessary. When it's harder to reach or its removal would significantly affect stomach- and intestine-related function, then using powerful drugs to help cure disease, radiation therapy or targeted therapy may be tried first. Surgery involves complete removal of the tumor, along with surrounding tissue. To restore function of the esophagus or stomach, a procedure called communication maybe did to connect the remaining healthy parts of of the organ. Some liver cancer patients could be able to be picked for transplantation. For very advanced cases of stomach- and intestine-related cancer that can't be effectively treated, doctors may aim to help reduce signs of sickness rather than cure the disease [3-4].

Conclusion

Research in molecular study of living things and the study of tiny chemical assembly instructions inside of living things has produced answers to the basic questions left unanswered by classical the study of tiny chemical assembly instructions inside of living things about the make-up of tiny chemical assembly instructions inside of living things, the method of tiny chemical assembly instruction inside of living things answer, what tiny chemical assembly instructions inside of living things do, and the way that tiny chemical assembly instruction inside of living things differences bring about phenotypic differences. These answers are surrounded by/expressed by terms of molecular level important events or patterns of things and they provide much of the basic explanation of why something works or happens the way it does connected with molecular the study of tiny chemical assembly instructions inside of living things.

References

1. Fukata, M., and M. T. Abreu. "TLR4 signalling in the intestine in health and disease." Biochemical Society Transactions 35 (2007): 1473-1478.
2. Burnstock, Geoffrey. "Purinergic signalling in the gastrointestinal tract and related organs in health and disease." Purinergic signalling 10 (2014): 3-50.
3. Grenham, Sue, Gerard Clarke, John F. Cryan, and Timothy G. Dinan. "Brain–gut–microbe communication in health and disease." Frontiers in physiology 2 (2011): 94.
4. Sekirov, Inna, Shannon L. Russell, L. Caetano M. Antunes, and B. Brett Finlay. "Gut microbiota in health and disease." Physiological reviews (2010).